共 6 条
[3]
[5]
Final results of a double-blind placebo-controlled study of adjuvant marimastat in small cell lung cancer (SCLC) patients responding to standard therapy.[J].G. Giaccone;F. Shepherd;C. Debruyne;V. Hirsh;M. Smylie;S. Rubin;H. Martins;A. Lamont;M. Krzakowski;B. Zee.European Journal of Cancer.2001,
[6]
Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state 1 1 Edited by R. Huber.[J].Anne-Laure Gall;Marc Ruff;Rama Kannan;Philippe Cuniasse;Athanasios Yiotakis;Vincent Dive;Marie-Christine Rio;Paul Basset;Dino Moras.Journal of Molecular Biology.2001, 2

